Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 178.67%209.81M | ---- | 2,111.75%75.29M | ---- | 112.30%3.4M | ---- | 8.62%-27.67M | ---- | -20.75%-30.28M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -191.15%-1.45M | ---- | -201.21%-497K | ---- | -1,000.00%-165K | ---- | -15.38%-15K | ---- | 23.53%-13K | ---- |
| Dividend (income)- adjustment | -104.96%-785K | ---- | -439.44%-383K | ---- | ---71K | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---64.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | -75.17%481K | ---- | -73.52%1.94M | ---- | -1.75%7.31M | ---- | -18.31%7.44M | ---- | -5.53%9.11M | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --937K | ---- |
| -Impairment of trade receivables (reversal) | -72.20%802K | ---- | -53.58%2.89M | ---- | -15.45%6.22M | ---- | 4.18%7.35M | ---- | 623.69%7.06M | ---- |
| -Other impairments and provisions | 66.14%-321K | ---- | -186.26%-948K | ---- | 1,081.72%1.1M | ---- | -91.69%93K | ---- | -87.09%1.12M | ---- |
| Revaluation surplus: | 30.75%-72.11M | ---- | -330.57%-104.13M | ---- | -366.52%-24.18M | ---- | 13.03%9.07M | ---- | 317.21%8.03M | ---- |
| -Other fair value changes | 30.75%-72.11M | ---- | -330.57%-104.13M | ---- | -366.52%-24.18M | ---- | 13.03%9.07M | ---- | 317.21%8.03M | ---- |
| Asset sale loss (gain): | --4K | ---- | ---- | ---- | ---- | ---- | 92.78%-204K | ---- | -2,313.68%-2.82M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | --4K | ---- | ---- | ---- | ---- | ---- | -219.51%-196K | ---- | 270.83%164K | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | 99.73%-8K | ---- | -14,128.57%-2.99M | ---- |
| Depreciation and amortization: | 8.13%4.31M | ---- | 37.65%3.99M | ---- | 49.15%2.9M | ---- | -0.41%1.94M | ---- | -45.59%1.95M | ---- |
| -Amortization of intangible assets | 152.57%2.01M | ---- | 86.65%797K | ---- | 84.05%427K | ---- | --232K | ---- | ---- | ---- |
| Financial expense | -18.28%7.51M | ---- | 900.65%9.19M | ---- | 4.68%918K | ---- | 22.66%877K | ---- | -41.54%715K | ---- |
| Special items | ---- | ---- | --3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | 669.33%83.18M | ---- | -47.74%-14.61M | ---- | -15.63%-9.89M | ---- | 35.76%-8.55M | ---- | -13.83%-13.31M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -565.78%-244.01M | ---- | ---36.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | -171.00%-339.08M | ---- | -1,060.33%-125.12M | ---- | 201.15%13.03M | ---- | 18.17%-12.88M | ---- | -156.94%-15.74M | ---- |
| Accounts payable increase (decrease) | 234.08%114.08M | ---- | 658.87%34.15M | ---- | -195.98%-6.11M | ---- | 10,046.88%6.37M | ---- | 99.52%-64K | ---- |
| Financial assets at fair value (increase)decrease | -56.27%3.33M | ---- | 39.56%7.62M | ---- | 170.34%5.46M | ---- | 17.96%-7.76M | ---- | -33.23%-9.46M | ---- |
| Special items for working capital changes | 520.28%428.01M | ---- | 557.03%69M | ---- | ---15.1M | ---- | ---- | ---- | -44.62%4.95M | ---- |
| Cash from business operations | 169.38%45.52M | ---- | -420.40%-65.61M | ---- | 44.77%-12.61M | ---- | 32.11%-22.83M | ---- | -857.64%-33.62M | ---- |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -185.66%-227K | ---- |
| Other taxs | -6,988.46%-1.84M | ---- | ---26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of business | ---- | 68.30%-11.28M | ---- | 19.69%-35.59M | ---- | 0.17%-44.31M | ---2.79M | 46.59%-44.39M | ---- | ---83.11M |
| Net cash from operations | 166.54%43.68M | 68.30%-11.28M | -420.61%-65.64M | 19.69%-35.59M | 50.79%-12.61M | 0.17%-44.31M | 24.31%-25.62M | 46.59%-44.39M | -819.77%-33.85M | -45.83%-83.11M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 191.15%1.45M | ---- | 300.81%497K | ---- | 726.67%124K | ---- | 15.38%15K | ---- | -23.53%13K | ---- |
| Dividend received - investment | 104.96%785K | ---- | 439.44%383K | ---- | --71K | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---91.73M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | 27.11%211K | ---- | -26.55%166K | ---- |
| Purchase of fixed assets | -463.79%-654K | ---- | 95.03%-116K | ---- | -667.76%-2.33M | ---- | -133.85%-304K | ---- | 88.12%-130K | ---- |
| Purchase of intangible assets | 39.58%-7.57M | ---- | -224.96%-12.52M | ---- | -106.87%-3.85M | ---- | 13.91%-1.86M | ---- | ---2.16M | ---- |
| Sale of subsidiaries | --21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | -140.74%-50.56M | ---- | ---21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | -2,082.86%-109.25M | ---- | -54.19%-5.01M | ---- | -332.80%-3.25M | ---- | 43.86%-750K | ---- | 91.35%-1.34M |
| Net cash from investment operations | -288.52%-127.28M | -2,082.86%-109.25M | -446.64%-32.76M | -54.19%-5.01M | -208.76%-5.99M | -332.80%-3.25M | 8.23%-1.94M | 43.86%-750K | -148.53%-2.12M | 91.35%-1.34M |
| Net cash before financing | 15.04%-83.6M | -196.92%-120.53M | -428.99%-98.4M | 14.64%-40.6M | 32.52%-18.6M | -5.36%-47.56M | 23.36%-27.56M | 46.54%-45.14M | -1,033.70%-35.97M | -16.56%-84.44M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 515.00%123M | ---- | 150.00%20M | ---- | 166.67%8M | ---- | --3M | ---- | ---- | ---- |
| Refund | -150.00%-20M | ---- | -166.67%-8M | ---- | ---3M | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | ---- | -13.74%78.19M | ---- | 836.01%90.65M | ---- | -82.39%9.69M | ---- | 34.55%55M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---429K | ---- | ---- | ---- |
| Other items of the financing business | 18.88%-7.21M | -32.25%50.86M | -988.97%-8.89M | -20.92%75.06M | -397.56%-816K | 5,611.25%94.92M | 0.00%-164K | -95.36%1.66M | 86.59%-164K | 85.73%35.81M |
| Net cash from financing operations | 19.51%94.13M | -32.25%50.86M | -15.20%78.77M | -20.92%75.06M | 751.66%92.88M | 5,611.25%94.92M | -79.50%10.91M | -95.36%1.66M | 65.11%53.2M | 85.73%35.81M |
| Effect of rate | -207.20%-2.58M | 33.14%-2.4M | -3.42%2.4M | -180.66%-3.59M | 20.89%2.49M | 318.80%4.46M | 235.75%2.06M | 75.29%1.06M | -65.86%-1.52M | 212.89%607K |
| Net Cash | 153.62%10.53M | -302.15%-69.68M | -126.43%-19.63M | -27.22%34.47M | 545.92%74.28M | 208.93%47.36M | -196.68%-16.66M | 10.60%-43.48M | -52.23%17.23M | 8.52%-48.63M |
| Begining period cash | -9.69%160.58M | -9.69%160.58M | 75.98%177.81M | 75.98%177.81M | -12.63%101.04M | -12.63%101.04M | 15.73%115.64M | 15.73%115.64M | 54.28%99.92M | 54.28%99.92M |
| Cash at the end | 4.95%168.53M | -57.59%88.5M | -9.69%160.58M | 36.52%208.68M | 75.98%177.81M | 108.75%152.85M | -12.63%101.04M | 41.09%73.22M | 15.73%115.64M | 339.85%51.9M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | Bofa Certified Public Accountants Co., Ltd. | -- | Bofa Certified Public Accountants Co., Ltd. | -- | Bofa Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.